{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:27:56Z","timestamp":1773667676167,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T00:00:00Z","timestamp":1405900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6823-14-61","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T17:02:28Z","timestamp":1405962148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Taner","family":"Damci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Emral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Louise","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzer","family":"Balkir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiten","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"issue":"Suppl 1","key":"311_CR1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association: Standards of medical care in diabetes--2013. Diabetes Care. 2013, 36 (Suppl 1): S11-S66.","journal-title":"Diabetes Care"},{"issue":"Suppl 5A","key":"311_CR2","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1016\/j.amjmed.2005.04.011","volume":"118","author":"IB Hirsch","year":"2005","unstructured":"Hirsch IB: Intensifying insulin therapy in patients with type 2 diabetes mellitus. Am J Med. 2005, 118 (Suppl 5A): 21S-26S.","journal-title":"Am J Med"},{"key":"311_CR3","first-page":"213","volume":"2","author":"K Poon","year":"2010","unstructured":"Poon K, King AB: Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs. Drug Healthc Patient Saf. 2010, 2: 213-223.","journal-title":"Drug Healthc Patient Saf"},{"key":"311_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6823-12-21","volume":"12","author":"M Jakobsen","year":"2012","unstructured":"Jakobsen M, Dalsgaard M, Hormann M, Moller DV: Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients. BMC Endocr Disord. 2012, 12: 21-","journal-title":"BMC Endocr Disord"},{"key":"311_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1753-0407.2011.00137.x","volume":"3","author":"ST Tsai","year":"2011","unstructured":"Tsai ST, Pathan F, Ji L, Yeung VT, Chadha M, Suastika K, Son HS, Tan KE, Benjasuratwong Y, Nguyen TK, Iqbal F: First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. J Diabetes. 2011, 3: 208-216. 10.1111\/j.1753-0407.2011.00137.x.","journal-title":"J Diabetes"},{"key":"311_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1742-1241.2010.02520.x","volume":"64","author":"J Gordon","year":"2010","unstructured":"Gordon J, Pockett RD, Tetlow AP, McEwan P, Home PD: A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. Int J Clin Pract. 2010, 64: 1609-1618. 10.1111\/j.1742-1241.2010.02520.x.","journal-title":"Int J Clin Pract"},{"key":"311_CR7","volume-title":"Ethical Principles for Medical Research Involving Human Patients","author":"Declaration of Helsinki","year":"2000","unstructured":"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Patients. 2000, Edinburgh, Scotland: 52nd WMA General Assembly, Ref Type: Internet Communication"},{"key":"311_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/pds.1471","volume":"17","author":"International Society of Pharmacoepidemiology","year":"2008","unstructured":"International Society of Pharmacoepidemiology: Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf. 2008, 17: 200-208. 10.1002\/pds.1471.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"311_CR9","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Harmonised Tripartite Guideline. Available online from \n                    http:\/\/www.ich.org\/products\/guidelines\/"},{"key":"311_CR10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1463-1326.2012.01602.x","volume":"14","author":"K Khunti","year":"2012","unstructured":"Khunti K, Damci T, Meneghini L, Pan CY, Yale JF: Study of Once Daily Levemir (SOLVE): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes Obes Metab. 2012, 14: 654-661. 10.1111\/j.1463-1326.2012.01602.x.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1463-1326.2012.01665.x","volume":"14","author":"K Khunti","year":"2012","unstructured":"Khunti K, Caputo S, Damci T, Dzida GJ, Ji Q, Kaiser M, Karnieli E, Liebl A, Ligthelm RJ, Nazeri A, Orozco-Beltran D, Pan C, Ross SA, Svendsen AL, Vora J, Yale JF, Meneghini LF: The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obes Metab. 2012, 14: 1129-1136.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4158\/EP12269.OR","volume":"19","author":"S Caputo","year":"2013","unstructured":"Caputo S, Andersen H, Kaiser M, Karnieli E, Meneghini LF, Svendsen AL: Effect of baseline HBA1C on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice. Endocr Pract. 2013, 19: 462-470. 10.4158\/EP12269.OR.","journal-title":"Endocr Pract"},{"key":"311_CR13","first-page":"314","volume":"6","author":"A Onat","year":"2006","unstructured":"Onat A, Hergenc G, Uyarel H, Can G, Ozhan H: Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyol Derg. 2006, 6: 314-321.","journal-title":"Anadolu Kardiyol Derg"},{"key":"311_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10654-013-9771-5","volume":"28","author":"I Satman","year":"2013","unstructured":"Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J, TURDEP-II Study Group: Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013, 28: 169-180. 10.1007\/s10654-013-9771-5.","journal-title":"Eur J Epidemiol"},{"key":"311_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0145721710388426","volume":"37","author":"RM Cuddihy","year":"2011","unstructured":"Cuddihy RM, Philis-Tsimikas A, Nazeri A: Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ. 2011, 37: 111-123. 10.1177\/0145721710388426.","journal-title":"Diabetes Educ"},{"key":"311_CR16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012, 35: 1364-1379. 10.2337\/dc12-0413.","journal-title":"Diabetes Care"},{"key":"311_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diabres.2008.04.007","volume":"81","author":"M Monami","year":"2008","unstructured":"Monami M, Marchionni N, Mannucci E: Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2008, 81: 184-189. 10.1016\/j.diabres.2008.04.007.","journal-title":"Diabetes Res Clin Pract"},{"key":"311_CR18","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2165\/00003495-200464220-00008","volume":"64","author":"TM Chapman","year":"2004","unstructured":"Chapman TM, Perry CM: Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs. 2004, 64: 2577-2595. 10.2165\/00003495-200464220-00008.","journal-title":"Drugs"},{"key":"311_CR19","first-page":"CD005613","volume":"18","author":"K Horvath","year":"2007","unstructured":"Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A: Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007, 18: CD005613-","journal-title":"Cochrane Database Syst Rev"},{"key":"311_CR20","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.clinthera.2007.08.020","volume":"29","author":"P Mullins","year":"2007","unstructured":"Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU: Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus. Clin Ther. 2007, 29: 1607-1619. 10.1016\/j.clinthera.2007.08.020.","journal-title":"Clin Ther"},{"key":"311_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","volume":"51","author":"J Rosenstock","year":"2008","unstructured":"Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G: A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia. 2008, 51: 408-416. 10.1007\/s00125-007-0911-x.","journal-title":"Diabetologia"},{"key":"311_CR22","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.clinthera.2008.11.001","volume":"30","author":"P Hollander","year":"2008","unstructured":"Hollander P, Cooper J, Bregnhoj J, Pedersen CB: A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Clin Ther. 2008, 30: 1976-1987. 10.1016\/j.clinthera.2008.11.001.","journal-title":"Clin Ther"},{"key":"311_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/dom.12083","volume":"15","author":"L Meneghini","year":"2013","unstructured":"Meneghini L, Kesavadev J, Demissie M, Nazeri A, Hollander P: Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes. Diabetes Obes Metab. 2013, 15: 729-736. 10.1111\/dom.12083.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa075392","volume":"357","author":"RR Holman","year":"2007","unstructured":"Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, 4-T Study Group: Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007, 357: 1716-1730. 10.1056\/NEJMoa075392.","journal-title":"N Engl J Med"},{"key":"311_CR25","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","volume":"361","author":"RR Holman","year":"2009","unstructured":"Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, 4-T Study Group: Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009, 361: 1736-1747. 10.1056\/NEJMoa0905479.","journal-title":"N Engl J Med"},{"key":"311_CR26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.clinthera.2006.10.020","volume":"28","author":"A Philis-Tsimikas","year":"2006","unstructured":"Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B: Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther. 2006, 28: 1569-1581. 10.1016\/j.clinthera.2006.10.020.","journal-title":"Clin Ther"},{"key":"311_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1742-1241.2008.01715.x","volume":"62","author":"A Dornhorst","year":"2008","unstructured":"Dornhorst A, Luddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L: Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study. Int J Clin Pract. 2008, 62: 659-665. 10.1111\/j.1742-1241.2008.01715.x.","journal-title":"Int J Clin Pract"},{"key":"311_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1185\/03007990902840871","volume":"25","author":"LF Meneghini","year":"2009","unstructured":"Meneghini LF, Dornhorst A, Sreenan S: Once-daily insulin detemir in a cohort of insulin-naive patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study. Curr Med Res Opin. 2009, 25: 1029-1035. 10.1185\/03007990902840871.","journal-title":"Curr Med Res Opin"},{"key":"311_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1463-1326.2004.00373.x","volume":"7","author":"T Haak","year":"2005","unstructured":"Haak T, Tiengo A, Draeger E, Suntum M, Waldhausl W: Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab. 2005, 7: 56-64. 10.1111\/j.1463-1326.2004.00373.x.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1463-1326.2007.00756.x","volume":"9","author":"T Heise","year":"2007","unstructured":"Heise T, Pieber TR: Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab. 2007, 9: 648-659. 10.1111\/j.1463-1326.2007.00756.x.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1055\/s-0029-1243230","volume":"118","author":"A Tone","year":"2010","unstructured":"Tone A, Iseda I, Higuchi C, Tsukamoto K, Katayama A, Matsushita Y, Hida K, Wada J, Shikata K: Comparison of insulin detemir and insulin glargine on glycemic variability in patients with type 1 and type 2 diabetes. Exp Clin Endocrinol Diabetes. 2010, 118: 320-324. 10.1055\/s-0029-1243230.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"311_CR32","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2337\/dc09-2294","volume":"33","author":"SG Swinnen","year":"2010","unstructured":"Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, Pfeiffer AF, Snoek FJ, Devries JH, Hoekstra JB, Holleman F: A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care. 2010, 33: 1176-1178. 10.2337\/dc09-2294.","journal-title":"Diabetes Care"},{"key":"311_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1463-1326.2006.00665.x","volume":"9","author":"K Hermansen","year":"2007","unstructured":"Hermansen K, Davies M: Does insulin detemir have a role in reducing risk of insulin-associated weight gain?. Diabetes Obes Metab. 2007, 9: 209-217. 10.1111\/j.1463-1326.2006.00665.x.","journal-title":"Diabetes Obes Metab"},{"key":"311_CR34","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2337\/diacare.28.12.2948","volume":"28","author":"NN Zammitt","year":"2005","unstructured":"Zammitt NN, Frier BM: Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005, 28: 2948-2961. 10.2337\/diacare.28.12.2948.","journal-title":"Diabetes Care"},{"key":"311_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00125-008-1147-0","volume":"52","author":"SG Swinnen","year":"2009","unstructured":"Swinnen SG, Mullins P, Miller M, Hoekstra JB, Holleman F: Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia. 2009, 52: 38-41. 10.1007\/s00125-008-1147-0.","journal-title":"Diabetologia"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6823-14-61\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6823-14-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6823-14-61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6823-14-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T17:04:42Z","timestamp":1548176682000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/1472-6823-14-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1186\/1472-6823-14-61","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,21]]},"assertion":[{"value":"11 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"61"}}